Research Highlights from ACTRIMS Forum 2023
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
Looking back at this past year in research, we reflect on key advances that are accelerating our understanding of multiple sclerosis (MS) and…
On October 26-28, 2022, the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered scientists, clinicians, and…
Canadians are known for many things – our hockey teams, maple syrup production, and universal healthcare come to mind – but our MS…
On October 13-15, the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) organized a fully digital experience…
Through the generous support of the MS community, event participants, and donors, the Multiple Sclerosis Society of Canada has invested over $204 million…
This blog post was published in October 2021 for #WorldMentalHealthDay to raise awareness of mental health as an integral part of overall health.…
Drs. Michelle Ploughman (Memorial University of Newfoundland) and Sarah Donkers (University of Saskatchewan) are set to lead the first Canadian clinical trial examining…
Multiple sclerosis (MS) is a disease that does not discriminate – it can affect anyone at any time, often in the prime of their lives. In…
Kelsi Smith is a Canadian who is pursuing her PhD in the area of neuroscience and epidemiology at Karolinska Insitutet. In 2020, Kelsi…